These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26390952)

  • 81. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
    Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
    Liu JY; Chen TJ; Hwang SJ
    Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis.
    Poggio F; Del Mastro L; Bruzzone M; Ceppi M; Razeti MG; Fregatti P; Ruelle T; Pronzato P; Massarotti C; Franzoi MA; Lambertini M; Tagliamento M
    Breast Cancer Res Treat; 2022 Jan; 191(2):269-275. PubMed ID: 34731351
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?
    Olsson H; Bladström A; Ingvar C
    Obstet Gynecol; 2003 Sep; 102(3):565-70. PubMed ID: 12962944
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hormone replacement therapy increases the risk of cranial meningioma.
    Andersen L; Friis S; Hallas J; Ravn P; Schrøder HD; Gaist D
    Eur J Cancer; 2013 Oct; 49(15):3303-10. PubMed ID: 23800670
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database.
    Inayama Y; Mizuno K; Yamaguchi K; Hamanishi J; Takeuchi M; Egawa M; Mandai M; Kawakami K
    J Obstet Gynaecol Res; 2023 Jul; 49(7):1805-1814. PubMed ID: 37029559
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study.
    DeCensi A; Bonanni B; Maisonneuve P; Serrano D; Omodei U; Varricchio C; Cazzaniga M; Lazzeroni M; Rotmensz N; Santillo B; Sideri M; Cassano E; Belloni C; Muraca M; Segnan N; Masullo P; Costa A; Monti N; Vella A; Bisanti L; D'Aiuto G; Veronesi U;
    Ann Oncol; 2013 Nov; 24(11):2753-60. PubMed ID: 23864098
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Breast cancer and hormone replacement therapy].
    Küng F; Maurer-Major E; Keller PJ
    Schweiz Med Wochenschr; 1999 Apr; 129(15):590-4. PubMed ID: 10355020
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
    Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
    JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 94. 20. Oral contraceptives, hormone replacement therapy and breast cancer.
    Fentiman IS
    Int J Clin Pract; 2002 Dec; 56(10):755-9. PubMed ID: 12510949
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.
    Bassuk SS; Manson JE
    Ann Epidemiol; 2015 Mar; 25(3):193-200. PubMed ID: 25534509
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy.
    Michaelson-Cohen R; Gabizon-Peretz S; Armon S; Srebnik-Moshe N; Mor P; Tomer A; Levy-Lahad E; Paluch-Shimon S
    Eur J Cancer; 2021 May; 148():95-102. PubMed ID: 33743487
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
    Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Effects of hormone replacement therapy for menopause on prognostic factors of breast cancer].
    Bonnier P; Sakr R; Bessenay F; Lejeune C; Charpin C; Martin PM; Piana L
    Gynecol Obstet Fertil; 2000 Oct; 28(10):745-53. PubMed ID: 11244637
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.